COMP <GO>
COLL vs AVBP // EV/EBITDA & P/E VALUATION
Collegium Pharmaceutical Inc. (NASDAQ) VS. ArriVent BioPharma Inc. (NASDAQ) • 15-METRIC TALLY: COLL 3
— AVBP 1
■ METRIC PARITY
LAST: $24.03 (+3.44%) • MKT CAP: $782.3M
valuation
3.0x
LAST: $15.95 (+1.40%) • MKT CAP: $786.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COLL VS. AVBP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COLL | AVBP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | -35.00% | +120.00 | COLL | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 3.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -20.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 23.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 8.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 23.60% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.27 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | COLL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.9 | 32.1 | +24.77 | COLL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $782.3M | $786.5M | -$4.1M | AVBP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COLL REV | AVBP REV | COLL GROSS % | AVBP GROSS % | COLL FCF | AVBP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $780.6M | $0 | 59.3% | — | $327.6M | -$160.6M |
| FY 2024 | $631.4M | $0 | 59.8% | — | $203.3M | -$70.2M |
| FY 2023 | $566.8M | $0 | — | — | $274.7M | -$55.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COLL // BETA —
AVBP // BETA —